Vita 34 AG Stock
Price
Target price
€4.46
€4.46
-0.900%
-0.04
-0.900%
-
26.07.24 / Tradegate
WKN: A0BL84 / Name: Vita 34 / Stock / Healthcare Providers & Services / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Vita 34 AG Stock
The price for the Vita 34 AG stock decreased slightly today. Compared to yesterday there is a change of -€0.040 (-0.900%).
So far the community has only identified positive things for Vita 34 AG stock. The most positive votes were given for criterium "Business model".
Pros and Cons of Vita 34 AG in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vita 34 AG vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Vita 34 AG | -0.900% | 0.000% | -0.889% | -10.621% | -14.885% | -72.298% | -62.521% |
Mediclin AG | -4.800% | -6.923% | 0.000% | -20.395% | -9.023% | -39.500% | -51.210% |
M1 Kliniken AG | -2.880% | -5.573% | -15.746% | 92.065% | 37.387% | 54.040% | - |
Surgery Partners Inc | 3.680% | 6.015% | 29.358% | -19.886% | -2.083% | -40.000% | 326.949% |
News
![EQS-News: Vita 34 significantly increases earnings and operating cash flow in the first quarter](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
EQS-News: Vita 34 significantly increases earnings and operating cash flow in the first quarter
EQS-News: Vita 34 significantly increases earnings and operating cash flow in the first quarter
![EQS-News: Vita 34 returns to growth path in 2023](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
EQS-News: Vita 34 returns to growth path in 2023
EQS-News: Vita 34 returns to growth path in 2023
![EQS-Adhoc: Vita 34 closes 2023 with significantly better results than expected based on preliminary figures](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
EQS-Adhoc: Vita 34 closes 2023 with significantly better results than expected based on preliminary figures
EQS-Adhoc: Vita 34 closes 2023 with significantly better results than expected based on preliminary figures